Conceptio
›
multiple-myeloma
Topic
multiple-myeloma
Knowledge-graph topic
· documents ABOUT multiple-myeloma across the archive
675
Documents about multiple-myeloma
Documents about multiple-myeloma
Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma
#373665
ClinicalTrials.gov
Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma
#856806
ClinicalTrials.gov
Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM
#885771
ClinicalTrials.gov
Daratumumab-containing Induction Effects on Stem Cells Mobilization, colLection and Engraftment in Newly Diagnosed Multiple MyelomA Patients.
#917397
ClinicalTrials.gov
PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
#918099
ClinicalTrials.gov
RO4929097 After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
#855392
ClinicalTrials.gov
B-Cell Hematologic Malignancy Vaccination Registry
#842477
ClinicalTrials.gov
Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma
#803173
ClinicalTrials.gov
Daratumumab, Bortezomib, and Dexamethasone With or Without Venetoclax in Treating Patients With Relapsed or Refractory Multiple Myeloma
#127570
ClinicalTrials.gov
Simvastatin in Overcoming Chemotherapy Resistance in Patients With Relapsed or Refractory Multiple Myeloma
#807626
ClinicalTrials.gov
Venetoclax and Tocilizumab for the Treatment of Patients With Relapsed or Refractory t(11;14) Multiple Myeloma
#843061
ClinicalTrials.gov
Étude des mécanismes de résistance des cellules du Myélome Multiple aux Immunothérapies
#194363
HAL (France)
Phase I/II Clinical Trial Combining hTERT Tumor Vaccine & Autologous T Cells in Patients With Advanced Myeloma
#253012
ClinicalTrials.gov
Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma
#807415
ClinicalTrials.gov
Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma
#981349
ClinicalTrials.gov
Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study
#992262
ClinicalTrials.gov
In Silico Screening of Natural Compounds as Novel Drug Targets for the Treatment of Multiple Myeloma
#200316
DigitalCommons@USU
GWAS-Identified Variants for Obesity Do Not Influence the Risk of Developing Multiple Myeloma: A Population-Based Study and Meta-Analysis
#330436
IRIS
Serum ICTP as a Marker of Bone Resorption and Its Association with Hematological and Biochemical Parameters in Multiple Myeloma
#427376
HAL (France)
Serologic follow-up in patients with multiple myeloma without repeated bone marrow studies: a single-institution experience.
#646481
PubMed
Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma
#804436
ClinicalTrials.gov
A Phase II Study of Dasatinib in the Treatment of Relapsed or Plateau Phase Multiple Myeloma
#804609
ClinicalTrials.gov
Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus Lenalidomide, Dexamethasone and MLN9708 After Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly-diagnosed Symptomatic Multiple Myeloma
#826295
ClinicalTrials.gov
Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.
#832374
ClinicalTrials.gov
Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)
#839357
ClinicalTrials.gov
Sequential High-dose Dexamethasone and Response Adopted PAD or VAD Induction Chemotherapy Followed by High-dose Chemotherapy With Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
#853986
ClinicalTrials.gov
Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients
#861188
ClinicalTrials.gov
An Open Label, Single-arm Clinical Study Evaluating the Safety and Efficacy of ICI201 Infusion in Relapsed/Refractory Multiple Myeloma
#864411
ClinicalTrials.gov
A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
#888003
ClinicalTrials.gov
Using Mass Spectrometry (EasyM) Detecting Minimal Residual Disease (MRD) in Multiple Myeloma
#894072
ClinicalTrials.gov
IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myeloma Patients
#897261
ClinicalTrials.gov
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
#905100
ClinicalTrials.gov
MC210808 Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) for the Treatment of Multiple Myeloma
#906354
ClinicalTrials.gov
Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome
#881346
ClinicalTrials.gov
Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or Refractory Multiple Myeloma, AMBUSH Trial
#148745
ClinicalTrials.gov
CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma
#387144
ClinicalTrials.gov
Pomalidomide or Lenalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Previously Treated With Lenalidomide
#916575
ClinicalTrials.gov
MyeGPT: an AI agent for Multiple Myeloma
#298234
bioRxiv / medRxiv
Precision Medicine Study
#831712
ClinicalTrials.gov
The Pathophysiology of Bortezomib Induced Peripheral Neuropathy
#982511
ClinicalTrials.gov
Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant
#832356
ClinicalTrials.gov
Treatment of Malignant Vertebral Fractures With Percutaneous Balloon Kyphoplasty.
#853193
ClinicalTrials.gov
Clinical Trial Using Humanized CART Directed Against BCMA (ARI0002h) in Patients With Relapsed/Refractory Multiple Myeloma to Proteasome Inhibitors, Immunomodulators and Anti-CD38 Antibody.
#853469
ClinicalTrials.gov
Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
#856337
ClinicalTrials.gov
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
#863566
ClinicalTrials.gov
A Dose-escalation Study to Evaluate the Safety and Clinical Activity of PBCAR269A, With or Without Nirogacestat, in Study Participants With Relapsed/Refractory Multiple Myeloma
#881160
ClinicalTrials.gov
A Study Assessing the Health-Related Quality of Life (HRQoL) in Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) With Triple Class Exposure
#881605
ClinicalTrials.gov
A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Participants With Relapsed and Refractory Multiple Myeloma
#886501
ClinicalTrials.gov
Evaluation of Vertebral Compression Fracture Fixation With RF Kyphoplasty in Patients With Multiple Myeloma
#891401
ClinicalTrials.gov
Retrospective Study to Describe Carfilzomib Use on Patients With Relapsed Multiple Myeloma in France in the Context of Carfilzomib Nominative Expanded Access and Compassionate Use
#894843
ClinicalTrials.gov
← Previous
Page 11 of 20
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.